Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2019
2019-11-04
Voluntary Announcement - Increase in Shareholding by Directors and Controlling Shareholders
2019-10-17
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
2019-10-02
Notification Letter with Request Form to Non-Registered Holders of Shares - Notice of Publication of Interim Report 2019
2019-09-24
2019 Interim Report
2019-09-24
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
2019-09-03
2019 Interim Results
2019-08-29
Voluntary Announcement - Investigational New Drug Approval for NASH Indication
2019-08-28
Notice of Board Meeting
2019-08-12
Voluntary Announcement - Investigational New Drug Approval for ASC18 and Management Outlook of 2019 and Beyond
2019-08-05

2

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1